Liraglutide , ≥99% , 204656-20-2
CAS NO.：204656-20-2
Empirical Formula: C172H265N43O51
Molecular Weight: 3751.2
MDL number: MFCD31689263
EINECS: 810-818-7
| Pack Size | Price | Stock | Quantity |
| 1mg | RMB959.20 | In Stock |
|
| 5mg | RMB3999.20 | In Stock |
|
| 25mg | RMB6399.20 | In Stock |
|
| 100mg | RMB10399.20 | In Stock |
|
| others | Enquire |
PRODUCT Properties
| Melting point: | >182°C (dec.) |
| storage temp. | Refrigerator |
| solubility | DMSO (Slightly), Water (Slightly) |
| form | Solid |
| color | White to Off-White |
| Sequence | H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala- |
| InChIKey | YSDQQAXHVYUZIW-VTFFJMQZNA-N |
Description and Uses
Liraglutide is a new type of hypoglycemic drug that activates AMP-activated protein kinase thus enhancing insulin sensitivity. It not only has a significant hypoglycemic effect, but also has the functions of weight loss, blood pressure reduction, and improvement of blood lipid profile.
Liraglutide, a human glucagon-like peptide-1 (GLP-1) receptor agonist, slows gastric emptying, increases satiety, and reduces patient eating, while reducing the brain's desire to eat and allowing the body to Increased energy expenditure plays a role in weight loss; it prevents the liver from producing too much glucose and promotes the pancreas to produce more insulin to lower blood sugar; in addition, liraglutide also has cardiovascular benefits and kidney protection.
Safety
| Symbol(GHS) |  GHS07 |
| Signal word | Warning |
| Hazard statements | H315-H319-H335 |
| Precautionary statements | P261-P305+P351+P338 |
| Hazardous Substances Data | 204656-20-2(Hazardous Substances Data) |
